Patient selection for ventricular assist devices: A moving target

Journal of the American College of Cardiology

Volumn 61, Issue 12, 2013, Pages 1209-1221

  Miller, Leslie W ^a   Guglin, Maya ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Criteria; Heart failure; LVAD; Selection

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BODY SIZE; CACHEXIA; CLINICAL EVALUATION; COMORBIDITY; DISEASE SEVERITY; HEART DISEASE; HEART FAILURE; HEART GRAFT; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; OBESITY; PATIENT ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SOCIAL PSYCHOLOGY; SURVIVAL RATE; TREATMENT INDICATION; VENTRICULAR ASSIST DEVICE; CROSS-SECTIONAL STUDY; DRUG CONTRAINDICATION; HEART ASSIST DEVICE; HEART TRANSPLANTATION; MORTALITY; PATIENT REFERRAL; PRACTICE GUIDELINE; PROGNOSIS; PROSTHESIS; REVIEW; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

CROSS-SECTIONAL STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSTHESIS DESIGN; REFERRAL AND CONSULTATION; SURVIVAL RATE; UNITED STATES; UTILIZATION REVIEW;

MLCS; MLOWN;

EID: 84877249258     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.08.1029     Document Type: Review

References (82)

1. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007;115:1563-70.
2. Zannad F, Briancon S, Juilliere Y, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 1999;33:734-42.
3. Miller LW. Left ventricular assist devices are underutilized. Circulation 2011;123:1552- 8; discussion 1558.
4. Hertz MI, Boucek MM, Edwards LB, et al. The ISHLT transplant registry: moving forward. J Heart Lung Transplant 2006;25:1179-85.
5. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. J Am Coll Cardiol 2005;46:e1- 82.
6. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1- e90.
7. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010;29:S1-39.
8. Tuzun E, Roberts K, Cohn WE, et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J 2007;34:406 -11.
9. Wood C, Maiorana A, Larbalestier R, Lovett M, Green G, O'Driscoll G. First successful bridge to myocardial recovery with a HeartWare HVAD. J Heart Lung Transplant 2008;27:695-7.
10. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twentyseventh official adult heart transplant report-2010. J Heart Lung Transplant 2010;29:1089 -103.
11. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435- 43.
12. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
13. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57: 1890-8.
14. John R, Naka Y, Smedira NG, et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg 2011;92:1406 -13; discussion 1413.
15. Pamboukian SV, Tallaj JA, Brown RN, et al. Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol. J Heart Lung Transplant 2011;30: 879-87.
16. Terracciano CM, Miller LW, Yacoub MH. Contemporary use of ventricular assist devices. Annu Rev Med 2010;61:255-70.
17. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twentyfourth official adult heart transplant report-2007. J Heart Lung Transplant 2007;26:769-81.
18. Nativi JN, Drakos SG, Kucheryavaya AY, et al. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2011;30:854-61.
19. John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010;140:174-81.
20. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:535- 41.
21. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009;208:755- 61; discussion 761-2.
22. Boyle AJ, Ascheim DD, Russo MJ, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011;30:402-7.
23. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285:190 -2.
24. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134:351- 8.
25. Patane F, Grassi R, Zucchetti MC, et al. The use of Impella Recover in the treatment of post-infarction ventricular septal defect: a new case report. Int J Cardiol 2010;144:313-5.
26. Hertz MI, Aurora P, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: introduction to the 2007 annual reports-100,000 transplants and going strong. J Heart Lung Transplant 2007;26:763- 8.
27. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010;122:173- 83.
28. Sims DB, Uriel N, Gonzalez-Costello J, et al. Human immunodeficiency virus infection and left ventricular assist devices: a case series. J Heart Lung Transplant 2011;30:1060-4.
29. Schaffer JM, Allen JG, Weiss ES, et al. Evaluation of risk indices in continuous-flow left ventricular assist device patients. Ann Thorac Surg 2009;88:1889 -96.
30. Ketchum ES, Moorman AJ, Fishbein DP, et al. Predictive value of the Seattle heart failure model in patients undergoing left ventricular assist device placement. J Heart Lung Transplant 2010;29:1021-5.
31. Teuteberg JJ, Ewald GA, Adamson RM, et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. J Am Coll Cardiol 2013;60:44 -51.
32. Tedford RJ, Hemnes AR, Russell SD, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 2008;1:213-9.
33. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006;25:1- 6.
34. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316 -24.
35. Kukucka M, Potapov E, Stepanenko A, et al. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg 2011;141:1009 -14.
36. Lee S, Kamdar F, Madlon-Kay R, et al. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant 2010;29:209 -15.
37. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010;105:1030 -5.
38. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999;68:2181- 4.
39. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002;73:745-50.
40. Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002;106:I198 -202.
41. Nakatani S, Thomas JD, Savage RM, Vargo RL, Smedira NG, McCarthy PM. Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation 1996;94:II216 -21.
42. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008;51:2163-72.
43. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316 -24.
44. Santambrogio L, Bianchi T, Fuardo M, et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg 2006;5:379-82.
45. Deswarte G, Kirsch M, Lesault PF, Trochu JN, Damy T. Right ventricular reserve and outcome after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2010;29:1196-8.
46. Bourge RC, Naftel DC, Costanzo-Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 1993;12:549-62.
47. Russell SD, Rogers JG, Milano CA, et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 2009;120:2352-7.
48. Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 2009;28:352-9.
49. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009;87:1072- 8.
50. Thomas BA, Logar CM, Anderson AE. Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation. Perit Dial Int 2012;32:386 -92.
51. Schaffer JM, Arnaoutakis GJ, Allen JG, et al. Bleeding complications and blood product utilization with left ventricular assist device implantation. Ann Thorac Surg 2011;91:740 -7; discussion 747-9.
52. Demirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the Heart- Mate II left ventricular assist device. J Heart Lung Transplant 2011;30:849 -53.
53. Frazier OH. Unforeseen consequences of therapy with continuousflow pumps. Circ Heart Fail 2010;3:647-9.
54. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005;24:105-9.
55. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009;137:208 -15.
56. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-9.
57. Grady KL, White-Williams C, Naftel D, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weightheight indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant 1999;18:750-63.
58. Lietz K, John R, Burke EA, et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 2001;72:277- 83.
59. Coyle LA, Ising MS, Gallagher C, et al. Destination therapy: one-year outcomes in patients with a body mass index greater than 30. Artif Organs 2010;34:93-7.
60. Zahr F, Genovese E, Mathier M, et al. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. Ann Thorac Surg 2011;92:1420-6.
61. Dhesi P, Simsir SA, Daneshvar D, Rafique A, Phan A, Schwarz ER. Left ventricular assist device as "bridge to weight loss" prior to transplantation in obese patients with advanced heart failure. Ann Transplant 2011;16:5-13.
62. Brewer RJ, Lanfear DE, Sai-Sudhakar CB, et al. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2012; 31:167-72.
63. Holdy K, Dembitsky W, Eaton LL, et al. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant 2005;24:1690-6.
64. Stepanenko A, Potapov EV, Jurmann B, et al. Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. J Heart Lung Transplant 2010;29:61-5.
65. Adamson RM, Stahovich M, Chillcott S, et al. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience. J Am Coll Cardiol 2011;57:2487-95.
66. Altimir S, Lupon J, Gonzalez B, et al. Sex and age differences in fragility in a heart failure population. Eur J Heart Fail 2005;7:798-802.
67. Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J Thorac Cardiovasc Surg 2004;127:264-6.
68. Schweiger M, Stepanenko A, Vierecke J, et al. Preexisting mitral valve prosthesis in patients undergoing left ventricular assist device implantation. Artif Organs 2012;36:49 -53.
69. Mokashi SA, Schmitto JD, Lee LS, et al. Ventricular assist device in patients with prosthetic heart valves. Artif Organs 2010;34:1030-4.
70. D'Ancona G, Pasic M, Buz S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg 2012;93:e89 -91.
71. George RS, Birks EJ, Radley-Smith RC, Khaghani A, Yacoub M. Bridge to transplantation with a left ventricular assist device for systemic ventricular failure after Mustard procedure. Ann Thorac Surg 2007;83:306-8.
72. Mehmood S, Blais D, Martin S, Sai-Sudhakar C. Heartmate XVE destination therapy for end-stage heart failure in a patient with human immunodeficiency virus. Interact Cardiovasc Thorac Surg 2009;9:909-10.
73. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21.
74. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg 2007;133:1573- 80.
75. Slaughter MS, Giridharan GA, Tamez D, et al. Transapical miniaturized ventricular assist device: design and initial testing. J Thorac Cardiovasc Surg 2011;142:668 -74.
76. Meyns B, Klotz S, Simon A, et al. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol 2009;54:79-86.
77. Meyns BP, Simon A, Klotz S, et al. Clinical benefits of partial circulatory support in New York Heart Association class IIIB and early class IV patients. Eur J Cardiothorac Surg 2011;39:693- 8.
78. Kormos RL, Gasior TA, Kawai A, et al. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996; 111:773- 82; discussion 782-3.
79. Fitzpatrick JR, 3rd, Frederick JR, Hsu VM, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008;27:1286-92.
80. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316 -24.
81. Baumwol J, Macdonald PS, Keogh AM, et al. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant 2011;30:888 -95.
82. Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012;125:3191-200.